1. Home
  2. DRTS vs DBL Comparison

DRTS vs DBL Comparison

Compare DRTS & DBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$7.25

Market Cap

546.5M

Sector

Health Care

ML Signal

HOLD

Logo DoubleLine Opportunistic Credit Fund of Beneficial Interest

DBL

DoubleLine Opportunistic Credit Fund of Beneficial Interest

HOLD

Current Price

$14.68

Market Cap

293.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRTS
DBL
Founded
2015
2011
Country
Israel
United States
Employees
125
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
546.5M
293.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DRTS
DBL
Price
$7.25
$14.68
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$8.67
N/A
AVG Volume (30 Days)
269.7K
74.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
8.67%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1,055.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.30
$14.46
52 Week High
$8.60
$16.01

Technical Indicators

Market Signals
Indicator
DRTS
DBL
Relative Strength Index (RSI) 52.24 39.57
Support Level $6.51 $14.46
Resistance Level $7.77 $15.56
Average True Range (ATR) 0.52 0.09
MACD -0.05 -0.01
Stochastic Oscillator 41.74 41.37

Price Performance

Historical Comparison
DRTS
DBL

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.

About DBL DoubleLine Opportunistic Credit Fund of Beneficial Interest

Doubleline Opportunistic Credit Fund operates as a closed-end management investment company. Its investment objective is to seek a high total investment return by providing a high level of current income and the potential for capital appreciation. The Fund invests in debt securities, residential and commercial mortgage-backed securities, asset-backed securities, U.S. Government securities, corporate debt, international sovereign debt, and short-term investments.

Share on Social Networks: